Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of the Effect of Hydrocortisone on Survival Without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22 - 26 Months of Age in Intubated Infants < 30 Weeks Gestation Age

NCT01353313 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.

NCT NCT01353313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01353313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of the Effect of Hydrocortisone on Survival Without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22 - 26 Months of Age in Intubated Infants < 30 Weeks Gestation Age
Lead sponsor
NICHD Neonatal Research Network
Phase
Phase 3
Overall status
Completed
Start date
August 11, 2011
Completion date
September 12, 2024
Enrollment
800 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, infant, newborn, infant, premature, infant, small for gestational age, infant, very low birth weight